QUOTED. 24 April 2020. Brian Chapman.
Medtech companies are struggling to manage their uncertainty by the COVID-19 pandemic while preparing to compete in a post-pandemic market. See what Brian Chapman, principal with consulting firm ZS, said about building interest for companies here.
“This is an opportunity to build a bit more of a relationship with the patient.” – Brian Chapman, principal, ZS
- Find out more: Interview: How Medtech Companies Are Preparing To Navigate Post-Pandemic Market
Click here for a free trial of Medtech Insight